Director of research with over 20 years experience in preclinical science and biotechnology. Proven ability to apply knowledge in oncology, immunology, hematology and stem cell biology to advance novel pathways for therapeutic intervention. Successful at leading programs to drive discovery and preclinical development of antibody and cell therapeutics. Experienced at lead selection and characterization, demonstrating in vivo efficacy and executing pre-IND studies for biologic and stem cell therapeutics. Cross-disciplinary project leader for multiple disease focused and antibody engineering programs. Most recently directed a preclinical program in myeloprogenitor stem cell and radiation biology at Cellerant Therapeutics. Results oriented, team building management style, able to direct cross-functional project teams to successfully complete complex programs.